SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Covid-19: New UK variant may be linked to increased death rate, early data indicate

(2021) Gareth Iacobucci   BMJ-British Medical Journal

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

(2021) Alexander Muik et al.   SCIENCE

Spread of SARS-CoV-2 in the Icelandic Population

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

(2020) Jingyou Yu et al.   SCIENCE

Setting the criteria for SARS-CoV-2 reinfection – six possible cases

(2020) Sara Tomassini et al.   JOURNAL OF INFECTION

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

(2020) Catherine F Houlihan et al.   LANCET

Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report

(2020) Marlies Mulder et al.   CLINICAL INFECTIOUS DISEASES

Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2

(2020) Vivek Gupta et al.   CLINICAL INFECTIOUS DISEASES

Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain

(2020) Jan Van Elslande et al.   CLINICAL INFECTIOUS DISEASES

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

(2020) Amin Addetia et al.   JOURNAL OF CLINICAL MICROBIOLOGY

What reinfections mean for COVID-19

(2020) Akiko Iwasaki   LANCET INFECTIOUS DISEASES

Genomic evidence for reinfection with SARS-CoV-2: a case study

(2020) Richard L Tillett et al.   LANCET INFECTIOUS DISEASES

Understanding protection from SARS-CoV-2 by studying reinfection

(2020) Julie Overbaugh   NATURE MEDICINE

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) Angkana T. Huang et al.   Nature Communications

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE